ProPublica Report: How the FDA Oversees Foreign Generic Drug Factories
What happened
According to ProPublica, its investigation found that the FDA's system gives some foreign drugmakers a special pass to keep sending generic drugs from substandard factories to the U.S. The headline asks why prescription drug supply is not tracked as closely as food and clothing origins.
When it started
The trend started on November 9, 2026, and the investigation was described as taking 14 months. The exact publication date of the article is not given in the material provided.
How it spread
ProPublica says it spent 14 months examining how the Food and Drug Administration regulates foreign drugmakers. The specific methods and sources are not described in the excerpt provided and would be in the full article.
Why it matters
The topic is gaining attention because it raises questions about the safety and oversight of generic medicines. Shares on Mastodon were reported, but the material does not state official responses or further developments.